Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a child's own stem cells strengthen a weak heart after surgery?

NCT ID NCT02781922

Recruiting now Disease control Sponsor: Metcela Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether injecting a child's own heart stem cells (JRM-001) after reconstructive surgery can improve heart function in children with single ventricle heart defects. About 40 children scheduled for Glenn or Fontan surgery will receive either the stem cells or a placebo. The main goal is to see if the treatment boosts the heart's pumping ability, measured by MRI.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPOPLASTIC LEFT HEART SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

congenital heart disease hypoplastic left heart syndrome univentricular heart

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HYPOPLASTIC LEFT HEART SYNDROME SINGLE-VENTRICLE

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Kanagawa Children's Medical Center

    RECRUITING

    Kanagawa, Japan

  • Okayama University Hospital

    RECRUITING

    Okayama, Japan

  • Saitama Prefectural Children's Medical Center

    RECRUITING

    Saitama, Japan

  • Shizuoka Children's Hospital

    RECRUITING

    Shizuoka, Japan

More trials for these conditions

Other studies related to the condition(s) this trial covers.